Zhou HB, Zhu JR. Paclitaxel induces apoptosis in human gastric carcinoma cells. World J Gastroenterol 2003; 9(3): 442-445 [PMID: 12632493 DOI: 10.3748/wjg.v9.i3.442]
Corresponding Author of This Article
Dr. Hai-Bo Zhou, Department Of Gastroenterology, Shandong Provincial Hospital, Jinan 250052, Shandong Province, China. zhouhbyy@fm365.com.cn
Article-Type of This Article
Gastric Cancer
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Hai-Bo Zhou, Ju-Ren Zhu, Department Of Gastroenterology, Shandong Provincial Hospital, Jinan 250052, Shandong Province, China
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Hai-Bo Zhou, Department Of Gastroenterology, Shandong Provincial Hospital, Jinan 250052, Shandong Province, China. zhouhbyy@fm365.com.cn
Telephone: +86-531-2603194
Received: August 3, 2002 Revised: October 8, 2002 Accepted: November 21, 2002 Published online: March 15, 2003
Abstract
AIM: To investigate the apoptosis in gastric cancer cells induced by paclitaxel, and the relation between this apoptosis and expression of Bcl-2 and Bax.
METHODS: In in vitro experiments, MTT assay was used to determine the cell growth inhibitory rate. Transmission electron microscope and TUNEL staining method were used to quantitatively and qualitively detect the apoptosis status of gastric cancer cell line SGC-7901 before and after the paclitaxel treatment. Immunohistochemical staining was used to detect the expression of apoptosis-regulated gene Bcl-2 and Bax.
RESULTS: Paclitaxel inhibited the growth of gastric cancer cell line SGC-7901 in a dose-and time-dependent manner. Paclitaxel induced SGC-7901 cells to undergo apoptosis with typically apoptotic characteristics, including morphological changes of chromatin condensation, chromatin crescent formation, nucleus fragmentation and apoptotic body formation. Paclitaxel could reduce the expression of apoptosis-regulated gene Bcl-2, and improve the expression of apoptosis-regulated gene Bax.
CONCLUSION: Paclitaxel is able to induce the apoptosis in gastric cancer. This apoptosis may be mediated by down-expression of apoptosis-regulated gene Bcl-2 and up-expression of apoptosis-regulated gene Bax.
Key Words: $[Keywords]
Citation: Zhou HB, Zhu JR. Paclitaxel induces apoptosis in human gastric carcinoma cells. World J Gastroenterol 2003; 9(3): 442-445
Apoptosis is a form of cell death characterized by active cellular suicide during T-cell clonal deletion, embryogenesis, and DNA damage. Apoptotic cell death is often associated with distinctive characteristics, such as nuclear fragmentation, cytoplasmic blebbing, and internucleosomal fragmentation of DNA. Whether a cell committed to apoptosis partly depends upon the balance between proteins that mediate cell death, such as Bax, and proteins that promote cell viability, such as Bcl-2 or Bcl-xl. Overpression of Bax has been shown to accelerate the cell death. Overpression of antiapoptotic proteins such as Bcl-2 represses the death function of Bax. Thus, the ratio of Bcl-2 to Bax appears to be a critical determinant of a cell’s threshold for undergoing apoptosis.
Microtubule inhibitors such as paclitaxel can increase tubulin polymerization, tubulin bundling, and cell cycle arrest. Paclitaxel have been proven to induce apoptosis in many cancers. In order to study the mechanism of paclitaxel induces apoptosis of SGC-7901 gastric cancer cells, MTT assay was used to determine the cell growth inhibitory rate. Transmission electron microscope and TUNEL staining method were used to quantitatively and qualitively detect the apoptosis status of gastric cancer cell line SGC-7901 before and after the paclitaxel treatment. Immunohistochemical staining was used to detect the expression of apoptosis-regulated gene Bcl-2 and Bax.
We report here the results of our findings showing paclitaxel inhibited the growth of gastric cancer cell line SGC-7901 in a dose-and time-dependent manner. Paclitaxel induced SGC-7901 cells to undergo apoptosis with typically apoptotic characteristics, including morphological changes of chromatin condensation, chromatin crescent formation, nucleus fragmentation and apoptotic body formation. Paclitaxel reduces Bcl-2 expression and improves Bax expression on SGC-7901 cells.
MATERIALS AND METHODS
Materials
Paclitaxel was obtained from Xiehe Pharmaceutical Factory in Biejing. MTT wAS obtained from Sigma Chemical Co. Ltd. Anti-Bcl-2 monoclonal antibody and anti-Bax monoclonal antibody were purchased from Beijing Zhongshan biotechnology Co. Ltd.
Methods
Cell culture Human gastric carcinoma cell line SGC-7901 was obtained from labaratory in Shandong Provincial Hospital and maintained in RPMI 1640 supplemented with 100 ml·L-1 fetal bovine serum, 100 kU·L-1 penicillin, 100 mg·L-1 streptomycin and 2 μmol·L-1 L-glutamine under 50 ml·L-1 CO2 in a humidified incubator at 37 °C. SGC-7901 cells were incubated for different time periods in the presence of paclitaxel at 0.001, 0.01, 0.1, 1 μmol·L-1.
MTT assay 1 × 105 cells/well in a 96-well plate after 24 h incubation were treated with increasing concentrations of paclitaxel (0.001 μmol·L-1 to 1 μmol·L -1) for 24 to 96 h. 10 µL of 5 g·L-1 of MTT was added to the cells in every well and incubated for 4 h at 37 °C. Culture media were discarded followed by addition of 0.2 ml of DMSO and vibration for 10 minutes. The absorbance (OD) was measured at 570 nm using a microplate reader. The cell growth inhibitory rate was calculated as follows: (OD of control group -OD of experimental group/OD of control group- OD of blank group) × 100%.
Transmission electron microscopy The cells treated with 0.1 μmol·L-1 paclitaxel were trypsinized and harvested after 24 h. Subsequently the cells were fixed in 4% glutaral and immersed with Epon 821, imbedded in capsules and converged for 72 h at 60 °C, the cells were prepared into ultrathin section (60 nm) and stained with uranyl acetate and lead citrate. Cell morphology was examined by transmission electron microscopy.
TUNEL assay Apoptosis of SGC-7901 cells was evaluated by using an in situ cell detection kit (Beijing Zhongshan biotechnology Co. Ltd). The cells were treated in the presence or absence of 0.1 μmol·L-1 paclitaxel for 24 to 96 h and fixed in ice-cold 80% ethanol for up to 24 h, treated with proteinase K and then 0.3% H2O2, labeled with fluorescein dUTP in a humid box for 1 h at 37 °C. The cells were then combined with POD-Horseradish peroxidase, colorized with DAB. Controls consisted of omission of fluorescein dUTP. Cells were visualized with light microscope. The Apoptotic Index (AI) was calculated as follows: AI = (Number of apoptotic cells/Total number) × 100%.
Immunohistochemical staining Immunohistochemical staining was accomplished utilizing an avidinbiotin technique. SGC-7901 cells treated in the presence or absence of 0.1 μmol·L-1 paclitaxel for 24 to 96 h were grown on six-well glass slides and fixed in acetone. After washing in PBS, the cells were incubated in 0.3% H2O2 solution at room temperature for 5 minutes. The cells then were incubated with anti-Bcl-2 or anti-Bax at a 1:300 dilution at 4 °C overnight. Following washing in PBS, the second antibody, biotinylated antirat Ig G, was added and the cells were incubated at room temperature for 1 h. After washing in PBS, ABC compound was added and then incubated at room temperature for 10 minutes. DAB was used as the chromagen. After ten minutes, the brown color signifying the presence of antigen bound to antibodies was detected by light microscopy and photographed at × 200. Controls consisted of omission of the primary antibody. The Positive Rate (PR) was calculated as follows: PR = (Number of positive cells/Total number) × 100%.
Statistical analysis
Data were analyzed employing the paired two-tailed Student t test, and significance was assumed at P < 0.05.
RESULTS
MTT assay
SGC-7901 cells were exposed to increasing concentrations (0.001 μmol·L-1 to 1 μmol·L-1) of commercially available paclitaxel for 24 to 96 h. Our results show a dose- and time-dependent increase in tumor cell mortality. The data were summarised in Table 1.
Table 1 The inhibitory effect of paclitaxel on SGC-7901 cells (inhibitory rate, %).
After treatment of SGC-7901 cells with paclitaxel (0.1 μmol·L-1) for 24 h, some cells appeared apoptotic characteristics including chromatin condensation, chromatin crescent formation, nucleus fragmentation and apoptotic body formation were seen by transmission electron microscope (Figure 1).
Figure 1 Paclitaxel-induced apoptosis in SGC-7901 cells with Transmission Electron Microscope Apoptotic cell with chro-matin condensation, chromatin crescent formation, nucleus fragmentation ( × 4000).
TUNEL assay
Positive staining located in the nucleus (Figure 2). The results showed after treatment of SGC-7901 cells with paclitaxel (0.1 μmol·L-1) for 24 to 96 h, the AIs were apparently increased with treat time (P < 0.05) (Table 2).
Table 2 Apoptotic Index (AI) of treated SGC-7901 cells by paclitaxel.
Figure 2 Apoptotic cells induced by paclitaxel with TUNEL assay ( × 200)
Expression of Bcl-2 proteins
Positive staining located in the cytoplasm). The results showed after treatment of SGC-7901 cells with paclitaxel (0.1 μmol·L-1) for 24 to 96 h, the PRs of Bcl-2 proteins were apparently reduced with treat time (P < 0.05) (Table 3). This suggested paclitaxel could reduce Bcl-2 expression.
Table 3 Positive Rate of Bcl-2 on treated SGC-7901 cells by paclitaxel.
Positive staining located in the cytoplasm. The results showed after treatment of SGC-7901 cells with paclitaxel (0.1 μmol·L-1) for 24 to 96 h, the PRs of Bax proteins were apparently improved with treat time (P < 0.05) (Table 4). This suggested paclitaxel could improve Bcl-2 expression.
Table 4 Positive Rate of Bax on treated SGC-7901 cells by paclitaxel.
Apoptosis is a form of cell death characterized by active cellular suicide during T-cell clonal deletion, embryogenesis, and DNA damage. Apoptotic cell death is often associated with distinctive characteristics, such as nuclear fragmentation, cytoplasmic blebbing, and internucleosomal fragmentation of DNA[1-6]. The Bcl-2 family plays a central role in the control of apoptosis. The family includes a number of proteins which have amino acid sequence homology, including anti-apoptotic members such as Bcl-2 and Bcl-xL, as well as pro-apoptotic members including Bax and Bad[7-10]. Overpression of Bax has been shown to accelerate the cell death[11-15]. Conversely, Overpression of antiapoptotic proteins such as Bcl-2 represses the death function of Bax[16-20]. Thus, the ratio of Bcl-2 to Bax appears to be a critical determinant of a cell’s threshold for undergoing apoptosis[21].
Microtubule inhibitors such as paclitaxel can increase tubulin polymerization, tubulin bundling, and cell cycle arrest[22-24]. Paclitaxel have been proven to induce apoptosis in many cancers[25-37]. In order to study the mechanism of paclitaxel induces apoptosis of SGC-7901gastric cancer cells, MTT assay was used to determine the cell growth inhibitory rate. Transmission electron microscope and TUNEL staining method were used to quantitatively and qualitively detect the apoptosis status of SGC-7901gastric cancer cell before and after the paclitaxel treatment. Immunohistochemical staining was used to detect the expression of apoptosis-regulated gene Bcl-2 and Bax.
In the present study, MTT assay was used to observe the effect of paclitaxel on the growth of SGC-7901 gastric carcinoma cells in vitro, indicating that the drug could inhibit the the growth of gastric carcinoma cells. Our results show a dose- and time-dependent increase in tumor cell mortality. Its concentration- and time-effect relationships were significant. TUNEL assay showed after treatment of SGC-7901 cells with paclitaxel (0.1 μmol·L-1)for 24 to 96 h, the AIs were aparently increased with treat time ( P < 0.0 5 ). Immunohistochemical staining was used to detect the expression of Bcl-2 proteins and Bax proteins. The results showed after treatment of SGC-7901 cells with paclitaxel (0.1 μmol·L-1) for 24 to 96 h, the PRs of Bcl-2 proteins were apparently reduced with treat time (P < 0.05), but the PRs of Bax proteins were apparently improved with treat time (P < 0.05). These suggested paclitaxel could reduce Bcl-2 expression and improve Bcl-2 expression. The ratio of Bcl-2 to Bax was decreased. The decreased ratio could trigger the apoptosis of SGC-7901 cells.
The research in our laboratory demonstrated paclitaxel is able to induce the apoptosis in gastric cancer. This apoptosis may be mediated by down-expression of apoptosis-regulated gene Bcl-2 and up-expression of apoptosis-regulated gene Bax. The mechanism of Paclitaxel as a chemotherapeutic drug in anti-gastric carcinoma chemotherapy should be further studied.
Gu Y, Zeng S, Qiu P, Peng D, Yan G. [Apoptosis of bovine trabecular meshwork cells induced by dexamethasone].Zhonghua Yanke Zazhi. 2002;38:302-304.
[PubMed] [DOI][Cited in This Article: ]
van der Woude CJ, Jansen PL, Tiebosch AT, Beuving A, Homan M, Kleibeuker JH, Moshage H. Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.Hum Pathol. 2002;33:686-692.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 53][Cited by in F6Publishing: 61][Article Influence: 2.8][Reference Citation Analysis (0)]
Bellosillo B, Villamor N, López-Guillermo A, Marcé S, Bosch F, Campo E, Montserrat E, Colomer D. Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia.Blood. 2002;100:1810-1816.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 91][Cited by in F6Publishing: 97][Article Influence: 4.4][Reference Citation Analysis (0)]
Mehta U, Kang BP, Bansal G, Bansal MP. Studies of apoptosis and bcl-2 in experimental atherosclerosis in rabbit and influence of selenium supplementation.Gen Physiol Biophys. 2002;21:15-29.
[PubMed] [DOI][Cited in This Article: ]
Demaria S, Volm MD, Shapiro RL, Yee HT, Oratz R, Formenti SC, Muggia F, Symmans WF. Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy.Clin Cancer Res. 2001;7:3025-3030.
[PubMed] [DOI][Cited in This Article: ]
Oyaizu H, Adachi Y, Okumura T, Okigaki M, Oyaizu N, Taketani S, Ikebukuro K, Fukuhara S, Ikehara S. Proteasome inhibitor 1 enhances paclitaxel-induced apoptosis in human lung adenocarcinoma cell line.Oncol Rep. 2001;8:825-829.
[PubMed] [DOI][Cited in This Article: ]
Li Y, Shi T, Zhao W. [The mechanism of docetaxel-induced apoptosis in human lung cancer cells].Zhonghua Zhong Liu Za Zhi. 2000;22:208-211.
[PubMed] [DOI][Cited in This Article: ]
Fowler CA, Perks CM, Newcomb PV, Savage PB, Farndon JR, Holly JM. Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells.Int J Cancer. 2000;88:448-453.
[PubMed] [DOI][Cited in This Article: ][Cited by in F6Publishing: 1][Reference Citation Analysis (0)]
Yu C, Wang S, Dent P, Grant S. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway.Mol Pharmacol. 2001;60:143-154.
[PubMed] [DOI][Cited in This Article: ]
Huisman C, Ferreira CG, Bröker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA, Giaccone G. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.Clin Cancer Res. 2002;8:596-606.
[PubMed] [DOI][Cited in This Article: ]
Hu L, Hofmann J, Lu Y, Mills GB, Jaffe RB. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.Cancer Res. 2002;62:1087-1092.
[PubMed] [DOI][Cited in This Article: ]
Qin YC, Qi YQ, Si JL, Lin J, Zhu JR, Liu JY. Paclitaxel induces apoptosis in human gastric cancer cells and influences on the activity of telomerase in vitro.Shijie Huaren Xiaohua Zazhi. 2001;9:1086-1087.
[PubMed] [DOI][Cited in This Article: ]
